New clinical data from Phase 1 trial of ZW191 to be presented in an oral presentation on April 21 Preclinical data highlight combination potential for ZW191, a folate receptor alpha (FR?)-targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results